Table 4. Potential maximum increase in daily phosphate binder pill burden (tablets/day rounded to the nearest half pill) with the most prescribed medications in Fresenius Kidney Care clinics.
| Medication | Sevelamer (tabs/day) | Calcium carbonate (tabs/day) | Calcium acetate (tabs/day) | Velphoro (tabs/day) † | Lanthanum Carbonate** (tabs/day) |
|---|---|---|---|---|---|
| Amlodipine | 5.5 | 5 | 4 | 1 | 1.5 |
| Lisinopril | 5.5 | 5 | 4 | 1 | 1.5 |
| Clonidine | 0 | 0 | 0 | 0 | 0 |
| Acetaminophen | 0 | 0 | 0 | 0 | 0 |
| Omeprazole | 9.5 | 9 | 6.5 | 1.5 | 3 |
*If the patient is using this product, dietary adjustment may offset need for extra dose; †assumes maximum binding; **assumes 500-mg dose. Calculations assume complete availability of phosphate from medications